Crescendo Biologics Ltd, a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, announces a new translational science collaboration with The Institute of Cancer Research, London, one of the world’s most influential cancer research organisations.
October 20, 2021
· 4 min read